Diskogenic microspurs as a major cause of intractable spontaneous intracranial hypotension
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received January 18, 2016
- Accepted in final form June 9, 2016
- First Published August 26, 2016.
Article Versions
- Previous version (August 26, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Jürgen Beck, MD*,
- Christian T. Ulrich, MD*,
- Christian Fung, MD,
- Jens Fichtner, MD,
- Kathleen Seidel, MD,
- Michael Fiechter, PhD,
- Kety Hsieh, MD,
- Michael Murek, MD,
- David Bervini, MD,
- Niklaus Meier, MD,
- Marie-Luise Mono, MD,
- Pasquale Mordasini, MD,
- Ekkehard Hewer, MD,
- Werner J. Z'Graggen, MD,
- Jan Gralla, MD and
- Andreas Raabe, MD
- Jürgen Beck, MD*,
(1) Boehringer Ingelheim
NONE
NONE
NONE
(1) transdermal pointer for neuronavigation, PCT/EP2014/056340
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Swiss National Science Foundation (SNF) #320030 135477 Swiss National Science Foundation (SNF) #150009
NONE
Swiss Heart Foundation, SWITCH Insel-Grant
NONE
NONE
NONE
NONE
NONE
NONE
- Christian T. Ulrich, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christian Fung, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Swiss Heart Foundation Inselspital Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Jens Fichtner, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Brainlab AG
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kathleen Seidel, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michael Fiechter, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kety Hsieh, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michael Murek, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Brainlab AG
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David Bervini, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Niklaus Meier, MD,
(1) Merz Pharma
NONE
(1) Ipsen Pharma, funding for travel to a scientific Meeting, (2) Bayer Healthcare, speaker honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marie-Luise Mono, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Swiss Heart Foundation, Grant
NONE
NONE
NONE
NONE
NONE
NONE
- Pasquale Mordasini, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ekkehard Hewer, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Werner J. Z'Graggen, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Swiss Foundation for Research on Muscle Diseases
NONE
NONE
NONE
NONE
NONE
NONE
- Jan Gralla, MD and
DSMB member for the Promise Study (Study on ischemic stroke, Sponsor: Penumbra)
NONE
Speakers honoraria since 2014 from Covidien
NONE
NONE
NONE
NONE
Former global PI of the STAR Study (strokeGlobal PI of the SWIFT Direct Trial (stoke)), therefore Consultant for Covidien
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andreas Raabe, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurosurgery (J.B., C.T.U., C.F., J.F., K.S., M.F., M.M., D.B., W.J.Z., A.R.), Neuroradiology (K.H., P.M., J.G.), Neurology (N.M., M.-L.M., W.J.Z.), and Neuropathology (E.H.), Inselspital, University Hospital, University of Bern, Switzerland.
- Correspondence to Dr. Beck: juergen.beck{at}insel.ch
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan